Susan Desmond-Hellmann
MD, MPH
Former CEO, Bill and Melinda Gates Foundation
👥Biography 个人简介
Susan Desmond-Hellmann led product development at Genentech where she oversaw the development and approval of bevacizumab and trastuzumab among other targeted cancer therapies. She subsequently served as Chancellor of UCSF and CEO of the Gates Foundation. Her leadership transformed biotechnology-based oncology drug development.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Susan Desmond-Hellmann 的研究动态
Follow Susan Desmond-Hellmann's research updates
留下邮箱，当我们发布与 Susan Desmond-Hellmann（Bill and Melinda Gates Foundation (historical)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment